BACCHETTI, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 992
AS - Asia 26
Totale 1.018
Nazione #
IT - Italia 992
CN - Cina 22
SG - Singapore 2
BD - Bangladesh 1
HK - Hong Kong 1
Totale 1.018
Città #
Genoa 814
Vado Ligure 168
Beijing 13
Bordighera 6
La Spezia 2
Singapore 2
Hong Kong 1
Milan 1
Turin 1
Totale 1.008
Nome #
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 100
The complex phenotype and function of spinal cord microglia during ALS progression and the impact of metabotropic glutamate receptor type 5 down-regulation in SOD1G93A mice 86
mGlu5 receptor negative allosteric modulation reduces the aberrant cellular reactivity and neurotoxicity of reactive human astrocytes differentiated from fibroblast of SOD1 and C9orf72 ALS patients 78
Anti Gram-Positive Bacteria Activity of Synthetic Quaternary Ammonium Lipid and Its Precursor Phosphonium Salt 76
Genetic and pharmacological effects by blocking mGlu5 receptor in the SOD1G93A mouse model of amyotrophic lateral sclerosis 67
Preclinical study showing a gender specific protective properties of conjugated linoleic acid (CLA) for amyotrophic lateral sclerosis 65
Therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 51
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 50
TPP-Based Nanovesicles Kill MDR Neuroblastoma Cells and Induce Moderate ROS Increase, While Exerting Low Toxicity Towards Primary Cell Cultures: An In Vitro Study 48
Combined motor and behavioural tracking approach to stratify ALS progression in SOD1(G93A) mice. 46
Synthesized Bis-Triphenyl Phosphonium-Based Nano Vesicles Have Potent and Selective Antibacterial Effects on Several Clinically Relevant Superbugs 44
Sex-specific motor and behavioural parameters for early stratification of ALS progression in SOD1(G93A) mice. 40
In-vitro and in-vivo studies showing the beneficial effects of extracellular vesicles derived from mesenchymal stem cells on the reactive astrocyte activation in amyotrophic lateral sclerosis 40
In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis 38
microRNAs shuttled by extracellular vesicles derived from mesenchymal stem cells revert glial activation and neurotoxicity in in-vitro models of amyotrophic lateral sclerosis 30
Preventive effects of conjugated linoleic acid (CLA) in-vivo oral treatment in the SOD1G93A preclinical model of amyotrophic lateral sclerosis 30
Phenotype changes of spinal cord microglia cells acutely purified from SOD1G93AALS mice during disease progression: focus on the genetic down regulation of mGlu5 receptor 29
Tri-Phenyl-Phosphonium-Based Nano Vesicles: A New In Vitro Nanomolar-Active Weapon to Eradicate PLX-Resistant Melanoma Cells 29
The negative allosteric modulator CTEP ameliorates the reactive phenotype of human-derived iAstrocytes differentiated from iNPCs of patients affected by Amyotrophic Lateral Sclerosis 28
Therapeutic effects of MSC-derived EVs intranasally administered on ALS mice 19
Intranasal in-vivo administration of MSC-derived EVs on ALS mice 15
Sex Differences in CASA-Mediated Autophagy in ALS Glial Cells 13
In vitro clustered cortical networks reveal NMDA-dependent modulation of repetitive activation sequences 12
Behavioral profiling of G93A mice in ALS progression. 10
Decoding behavioral patterns in G93A mice: insights and implications. 10
MYC-driven gliosis impairs neuron-glia communication in amyotrophic lateral sclerosis 4
null 1
null 1
Totale 1.060
Categoria #
all - tutte 3.423
article - articoli 751
book - libri 0
conference - conferenze 2.672
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.846


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202478 0 0 0 0 0 2 7 7 4 12 15 31
2024/2025537 34 23 14 35 40 52 50 90 15 45 68 71
2025/2026445 124 43 132 146 0 0 0 0 0 0 0 0
Totale 1.060